𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Silent coronary disease in diabetes — is it worth screening?

✍ Scribed by Shaw, Kenneth

Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
135 KB
Volume
11
Category
Article
ISSN
1357-8170

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Switching cholinesterase inhibitor thera
Switching cholinesterase inhibitor therapy in Alzheimer's disease—donepezil to rivastigmine, is it worth it?
✍ Roger Bullock; Claire Connolly 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB 👁 1 views

Switching from donepezil to rivastigmine was bene®cial in cognitive and global terms in 55.0% of the patients with Alzheimer's disease studied. \* Side-effects on donepezil and rivastigmine were independent of one another. \* It may be possible to extend the positive effects that cholinesterase inhi